FY2024 · ended Dec 31, 2024 · Revenue $50.92M, -45.6% YoY · Filed Apr 15, 2026
DNA X, Inc. (SONM) files with the SEC under industry code 3661, Telephone & Telegraph Apparatus.
Revenue (TTM)
$59.39M
+21.0% vs year-ago TTM
Net income (TTM)
$-33.38M
-149.4% vs year-ago TTM
Operating cash flow (TTM)
$-14.51M
+25.3% vs year-ago TTM
Free cash flow
$-8.70M
-112.8% vs prior year
EPS (TTM)
$-63.19
-471.7% vs year-ago TTM
Dividend per share
None
Shares outstanding
1.49M
+0.0% vs prior year
Net cash
$-3.76M
FY 2025
Operating margin
-2.7%
FY 2025
Company profile
- Industry
- Telephone & Telegraph Apparatus (SIC 3661)
- Listed as
- SONM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1178697
- Former names
- SONIM TECHNOLOGIES INC (until Jan 23, 2026)
Other Telephone & Telegraph Apparatus companies
- Ciena Corp CIEN
- Fabrinet FN
- Clearfield, Inc. CLFD
- ADTRAN Holdings, Inc. ADTN
- Audiocodes Ltd AUDC
- Franklin Wireless Corp FKWL
- Voip-pal.com Inc VPLM
- Clearone Inc CLRO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | — | $50.9M | $93.6M | $69.8M | $54.6M |
| Operating income | -$5.4M | -$3.1M | $513,000 | -$14.3M | -$38.0M |
| Net income | -$20.7M | -$33.6M | -$90,000 | -$14.1M | -$38.6M |
| Diluted EPS | -$28.58 | -$128.37 | -$0.02 | — | — |
| Operating cash flow | -$23.5M | -$8.5M | -$4.1M | -$12.4M | -$38.5M |
| Free cash flow | — | -$8.7M | -$4.1M | -$12.4M | -$38.5M |
| Total assets | $43.9M | $39.7M | $56.0M | $53.7M | $41.1M |
| Total liabilities | $50.6M | $45.4M | $33.7M | $33.6M | $22.5M |
| Stockholders' equity | -$8.0M | -$5.7M | $22.4M | $20.0M | $18.6M |
| Cash and investments | $1.3M | $5.3M | $9.4M | $13.2M | $11.2M |
| Total debt | $5.1M | — | $55,000 | $213,000 | $280,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Aug 31, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2026 | Aug 21, 2026 |
| 10-Q | Quarterly report | Aug 19, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Unregistered share sale, Other events
|
Aug 13, 2026 | Jun 29, 2026 |
| 8-K/A |
Amended current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 9, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Jul 2, 2026 | Jun 29, 2026 |
All 542 DNA X, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.